Clinical Trial Update: Montelukast With Status Asthmaticus, Ages 6-18 [Phase 2, Phase 3]

View source ↗

Summary

Montelukast is being studied in Phase 2/3 trials for status asthmaticus and asthma in children aged 6–18; the current trial status is Unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Status Asthmaticus

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Status Asthmaticus, Asthma | Phase 2, Phase 3 | Status: UNKNOWN